Ally Bridge Group led a $50m funding round in Ceribell.

Ally Bridge Group, a global healthcare investment management firm, led a $50m funding round in Ceribell, a medical device start-up company. "We are excited to partner with Ally Bridge and appreciate the continued support from our existing shareholders. Based on our progress to date, it is clear that the Ceribell Rapid EEG system is improving the quality of care seizure patients receive in the hospital. We look forward to continuing to bring this novel technology to more ICUs and Emergency Departments, as well as developing diagnostic and monitoring solutions for additional neurological indications impacting the lives of critically ill patients," Jane Chao, Founder and CEO Ceribell.